These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 10811118

  • 1. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.
    Hayes F, Cayanan C, Barillà D, Monteiro AN.
    Cancer Res; 2000 May 01; 60(9):2411-8. PubMed ID: 10811118
    [Abstract] [Full Text] [Related]

  • 2. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations.
    Williams RS, Chasman DI, Hau DD, Hui B, Lau AY, Glover JN.
    J Biol Chem; 2003 Dec 26; 278(52):53007-16. PubMed ID: 14534301
    [Abstract] [Full Text] [Related]

  • 3. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.
    Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brøndum-Nielsen K, Gerdes AM, Møller P, Kristoffersson U, Olsson H, Borg A, Monteiro AN.
    Hum Mol Genet; 2001 Feb 15; 10(4):353-60. PubMed ID: 11157798
    [Abstract] [Full Text] [Related]

  • 4. Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activation.
    Carvalho MA, Billack B, Chan E, Worley T, Cayanan C, Monteiro AN.
    Cancer Biol Ther; 2002 Feb 15; 1(5):502-8. PubMed ID: 12496477
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
    Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN.
    Cancer Res; 2004 Jun 01; 64(11):3790-7. PubMed ID: 15172985
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of a carboxy-terminal BRCA1 interacting protein.
    Wong AK, Ormonde PA, Pero R, Chen Y, Lian L, Salada G, Berry S, Lawrence Q, Dayananth P, Ha P, Tavtigian SV, Teng DH, Bartel PL.
    Oncogene; 1998 Nov 05; 17(18):2279-85. PubMed ID: 9811458
    [Abstract] [Full Text] [Related]

  • 12. [Mapping of BRCT1 domain of BRCA1 with chromatin unfolding activity].
    Ye QN, Hu YF, Zhong HJ, Li R, Huang CF.
    Sheng Wu Gong Cheng Xue Bao; 2002 Nov 05; 18(6):656-61. PubMed ID: 12674632
    [Abstract] [Full Text] [Related]

  • 13. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
    Bouwman P, van der Gulden H, van der Heijden I, Drost R, Klijn CN, Prasetyanti P, Pieterse M, Wientjens E, Seibler J, Hogervorst FB, Jonkers J.
    Cancer Discov; 2013 Oct 05; 3(10):1142-55. PubMed ID: 23867111
    [Abstract] [Full Text] [Related]

  • 14. A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein.
    Worley T, Vallon-Christersson J, Billack B, Borg A, Monteiro AN.
    Cancer Biol Ther; 2002 Oct 05; 1(5):497-501. PubMed ID: 12496476
    [Abstract] [Full Text] [Related]

  • 15. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.
    Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R.
    J Cell Biol; 2001 Dec 10; 155(6):911-21. PubMed ID: 11739404
    [Abstract] [Full Text] [Related]

  • 16. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M, Yu X, Chen J, Songyang Z.
    J Biol Chem; 2003 Dec 26; 278(52):52914-8. PubMed ID: 14578343
    [Abstract] [Full Text] [Related]

  • 17. Functional characterization of BRCA1 sequence variants using a yeast small colony phenotype assay.
    Coyne RS, McDonald HB, Edgemon K, Brody LC.
    Cancer Biol Ther; 2004 May 26; 3(5):453-7. PubMed ID: 15004537
    [Abstract] [Full Text] [Related]

  • 18. Evidence for a transcriptional activation function of BRCA1 C-terminal region.
    Monteiro AN, August A, Hanafusa H.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):13595-9. PubMed ID: 8942979
    [Abstract] [Full Text] [Related]

  • 19. Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.
    Carvalho M, Pino MA, Karchin R, Beddor J, Godinho-Netto M, Mesquita RD, Rodarte RS, Vaz DC, Monteiro VA, Manoukian S, Colombo M, Ripamonti CB, Rosenquist R, Suthers G, Borg A, Radice P, Grist SA, Monteiro AN, Billack B.
    Mutat Res; 2009 Jan 15; 660(1-2):1-11. PubMed ID: 18992264
    [Abstract] [Full Text] [Related]

  • 20. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, Joosse SA, Wong N, Novak D, Quenneville LA, Grist SA, kConFab, Nederlof PM, Goldgar DE, Tavtigian SV, Monteiro AN, Ladias JA, Foulkes WD.
    Eur J Hum Genet; 2008 Jul 15; 16(7):820-32. PubMed ID: 18285836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.